Protamine reversal of anticoagulation achieved with a low molecular weight heparin. The effects on eicosanoids, clotting and complement factors.
Hemodynamic and hematologic effects of protamine reversal of low molecular weight heparin (LMWH) anticoagulation with and without protamine pretreatment, as well as reversal of anticoagulation with unfractionated standard heparin (SH), were studied in canine subjects. Protamine reversal caused less severe thrombocytopenia in the two LMWH groups compared to SH animals, while neutropenia occurred equally in all groups. Cl-esterase inhibitor levels were minimally increased, whereas C3 levels and leucotriene levels were unaltered. TxB2 and 6-keto-PGF1 alpha increased during protamine reversal of LMWH anticoagulation. TCT and APTT were affected less with LMWH than SH anticoagulation. Anti-Xa levels increased with anticoagulation in all animals, but protamine did not reverse the elevated anti-Xa levels in LMWH anticoagulated dogs to the same degree as occurred with SH anticoagulation. TCT, APTT and bleeding times were normalized by protamine in all animals. Protamine reversal of LMWH anticoagulation with or without protamine pretreatment did not reveal any clear differences in eicosanoids or complement factors compared to SH anticoagulation, although differences in anti-Xa activity clearly separated these two heparins.
Lindblad
B
B
Department of Surgery, University of Michigan Medical School, Ann Arbor.
Borgström
A
A
Wakefield
T W
TW
Whitehouse
W M
WM
Stanley
J C
JC
D000818:Animals; D001769:Blood / Q000187:drug effects; D001777:Blood Coagulation / Q000187:drug effects*; D003165:Complement System Proteins / Q000378:metabolism*; D004285:Dogs; D004537:Eicosanoic Acids / Q000494:pharmacology*; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000037:antagonists & inhibitors*; D008297:Male; D011479:Protamines / Q000494:pharmacology*
D004537:Eicosanoic Acids; D006495:Heparin, Low-Molecular-Weight; D011479:Protamines; D003165:Complement System Proteins